{
    "b0": "Evolutionary determinants of cancer",
    "b1": "Clonal heterogeneity and tumor evolution: past, present, and the future",
    "b2": "Organoids in cancer research",
    "b3": "Interrogating open issues in cancer precision medicine with patient-derived xenografts",
    "b4": "The clinical relevance of cancer cell lines",
    "b5": "DNA repair, genome stability and cancer: a historical perspective",
    "b6": "Genetically engineered mouse models in oncology research and cancer medicine",
    "b7": "The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity",
    "b8": "Systematic identification of genomic markers of drug sensitivity in cancer cells",
    "b9": "An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules",
    "b10": "Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells",
    "b11": "Defining a cancer dependency map",
    "b12": "Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells",
    "b13": "A comprehensive transcriptional portrait of human cancer cell lines",
    "b14": "A molecularly annotated platform of patient-derived xenografts (\"xenopatients\") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer",
    "b15": "Patient-derived xenografts recapitulate molecular features of human uveal melanomas",
    "b16": "High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development",
    "b17": "The public repository of xenografts enables discovery and randomized phase II-like trials in mice",
    "b18": "Genetic and genomic characterization of 462 melanoma patient-derived xenografts, tumor biopsies, and cell lines",
    "b19": "A comprehensive patient-derived xenograft collection representing the heterogeneity of melanoma",
    "b20": "Personalized in vitro and in vivo cancer models to guide precision medicine",
    "b21": "Orthotopic patient-derived xenografts of paediatric solid tumours",
    "b22": "A PDX/organoid biobank of advanced prostate cancers captures genomic and phenotypic heterogeneity for disease modeling and therapeutic screening",
    "b23": "Genomic and functional fidelity of small cell lung cancer patient-derived xenografts",
    "b24": "High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response",
    "b25": "A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds",
    "b26": "Organoid cultures derived from patients with advanced prostate cancer",
    "b27": "Prospective derivation of a living organoid biobank of colorectal cancer patients",
    "b28": "Tumor evolution and drug response in patient-derived organoid models of bladder cancer",
    "b29": "A living biobank of breast cancer organoids captures disease heterogeneity",
    "b30": "Patient-derived organoids model treatment response of metastatic gastrointestinal cancers",
    "b31": "Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors",
    "b32": "Patient-derived xenograft models: an emerging platform for translational cancer research",
    "b33": "A new model of patient tumor-derived breast cancer xenografts for preclinical assays",
    "b34": "A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models",
    "b35": "Believe it or not: how much can we rely on published data on potential drug targets?",
    "b36": "Drug development: raise standards for preclinical cancer research",
    "b37": "Inconsistency in large pharmacogenomic studies",
    "b38": "pharmacogenomic agreement between two cancer cell line data sets",
    "b39": "Reproducible pharmacogenomic profiling of cancer cell line panels",
    "b40": "Reproducibility crisis in science or unrealistic expectations?",
    "b41": "The reproducibility \"crisis\": reaction to replication crisis should not stifle innovation",
    "b42": "Reproducibility crisis: blame it on the antibodies",
    "b43": "Measurement error and the replication crisis",
    "b44": "The ghosts of HeLa: how cell line misidentification contaminates the scientific literature",
    "b45": "Genetically engineered mouse models in cancer research",
    "b46": "Using CRISPR/Cas to study gene function and model disease in vivo",
    "b47": "Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential",
    "b48": "Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity",
    "b49": "The mutational landscapes of genetic and chemical models of Kras-driven lung cancer",
    "b50": "Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma",
    "b51": "The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis",
    "b52": "Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells",
    "b53": "germline mutation rates and the long-term phenotypic effects of mutation accumulation in wild-type laboratory mice and mutator mice",
    "b54": "",
    "b55": "A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains",
    "b56": "Alcohol trait and transcriptional genomic analysis of C57BL/6 substrains",
    "b57": "bone loss in c57bl/6j-olahsd mice, a substrain of c57bl/6j carrying mutated alpha-synuclein and multimerin-1 genes",
    "b58": "C57BL/6N mice are more resistant to ehrlich ascites tumors than C57BL/6J mice: the role of macrophage nitric oxide",
    "b59": "Mispairing C57BL/6 substrains of genetically engineered mice and wild-type controls can lead to confounding results as it did in studies of JNK2 in acetaminophen and concanavalin A liver injury",
    "b60": "Striking immune phenotypes in gene-targeted mice are driven by a copy-number variant originating from a commercially available C57BL/6 strain",
    "b61": "The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes",
    "b62": "Comparative genomic hybridization reveals extensive variation among different MCF-7 cell stocks",
    "b63": "Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor",
    "b64": "Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications",
    "b65": "Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function",
    "b66": "High variability of genomic instability and gene expression profiling in different HeLa clones",
    "b67": "Single-cell lineage tracking analysis reveals that an established cell line comprises putative cancer stem cells and their heterogeneous progeny",
    "b68": "Genetic and transcriptional evolution alters cancer cell line drug response",
    "b69": "",
    "b70": "Analysis of public RNA-sequencing data reveals biological consequences of genetic heterogeneity in cell line populations",
    "b71": "Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells",
    "b72": "Erosion of dosage compensation impacts human iPSC disease modeling",
    "b73": "Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis",
    "b74": "An ecosystem of cancer cell line factories to support a cancer dependency map",
    "b75": "ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells",
    "b76": "Integrated genetic and pharmacologic interrogation of rare cancers",
    "b77": "Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers",
    "b78": "Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria",
    "b79": "A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target",
    "b80": "Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues",
    "b81": "Patient-derived xenografts undergo mouse-specific tumor evolution",
    "b82": "Divergent evolutionary trajectories in transplanted tumor models",
    "b83": "Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution",
    "b84": "Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse",
    "b85": "Functional heterogeneity of genetically defined subclones in acute myeloid leukemia",
    "b86": "Prospective isolation and characterization of genetically and functionally distinct AML subclones",
    "b87": "Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance",
    "b88": "Organoid profiling identifies common responders to chemotherapy in pancreatic cancer",
    "b89": "Intra-tumour diversification in colorectal cancer at the single-cell level",
    "b90": "Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics",
    "b91": "Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells",
    "b92": "Chromosome segregation fidelity in epithelia requires tissue architecture",
    "b93": "Negative selection and chromosome instability induced by Mad2 overexpression delay breast cancer but facilitate oncogene-independent outgrowth",
    "b94": "Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice",
    "b95": "Raloxifene: a selective estrogen receptor modulator",
    "b96": "Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma",
    "b97": "Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer",
    "b98": "Microenvironmental regulation of therapeutic response in cancer",
    "b99": "Personalized in vitro cancer models to predict therapeutic response: challenges and a framework for improvement",
    "b100": "A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes",
    "b101": "whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer",
    "b102": "CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response",
    "b103": "p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells",
    "b104": "Genomic copy number dictates a gene-independent cell response to CRISPR/Cas9 targeting",
    "b105": "CRISPR screens provide a comprehensive assessment of cancer vulnerabilities but generate false-positive hits for highly amplified genomic regions",
    "b106": "Technologies for deriving primary tumor cells for use in personalized cancer therapy",
    "b107": "Pan-cancer analysis of the extent and consequences of intratumor heterogeneity",
    "b108": "In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer",
    "b109": "Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq",
    "b110": "Tumorigenesis: it takes a village",
    "b111": "Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity",
    "b112": "Heterogeneous tumor subpopulations cooperate to drive invasion",
    "b113": "SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations",
    "b114": "Senescence from glioma stem cell differentiation promotes tumor growth",
    "b115": "Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells",
    "b116": "Studying clonal dynamics in response to cancer therapy using high-complexity barcoding",
    "b117": "Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition",
    "b118": "genomic instability--an evolving hallmark of cancer",
    "b119": "Replication stress and cancer",
    "b120": "Determinants and clinical implications of chromosomal instability in cancer",
    "b121": "",
    "b122": "PyClone: statistical inference of clonal population structure in cancer",
    "b123": "synthex: a synthetic-normal-based dna sequencing tool for copy number alteration detection and tumor heterogeneity profiling",
    "b124": "",
    "b125": "A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers",
    "b126": "A genomic instability score in discriminating nonequivalent outcomes of BRCA1/2 mutations and in predicting outcomes of ovarian cancer treated with platinum-based chemotherapy",
    "b127": "Replication stress links structural and numerical cancer chromosomal instability",
    "b128": "",
    "b129": "Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profiles",
    "b130": "short- and long-term effects of chromosome mis-segregation and aneuploidy",
    "b131": "Single-chromosome gains commonly function as tumor suppressors",
    "b132": "Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells",
    "b133": "Pan-cancer patterns of somatic copy number alteration"
}
